 Amgen stock could get a fresh boost Thursday after the company unveiled promising results for its obesity treatment. The post Amgen Is The Underdog In Obesity Treatment But Its Creeping Up On Novo Nordisk, Eli Lilly appeared first on Investors Business Daily. 